NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program

Neurofibromatosis Type I (NF1) is caused by variants in neurofibromin (<i>NF1</i>). NF1 predisposes to a variety of benign and malignant tumor types, including breast cancer. Women with NF1 &lt;50 years of age possess an up to five-fold increased risk of developing breast cancer comp...

詳細記述

保存先:
書誌詳細
主要な著者: Nika Maani, Shelley Westergard, Joanna Yang, Anabel M. Scaranelo, Stephanie Telesca, Emily Thain, Nathan F. Schachter, Jeanna M. McCuaig, Raymond H. Kim
フォーマット: Artigo
言語:Inglês
出版事項: MDPI AG 2019-05-01
シリーズ:Cancers
主題:
breast cancer
neurofibromatosis type I
high-risk screening
screening uptake
オンライン･アクセス:https://www.mdpi.com/2072-6694/11/5/707
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料